Disturbed Complement Receptor Expression Pattern of B Cells Is Enhanced by Toll-like Receptor CD180 Ligation in Diffuse Cutaneous Systemic Sclerosis

被引:0
|
作者
Erdo-Bonyar, Szabina [1 ]
Rapp, Judit [1 ]
Subicz, Rovena [1 ]
Borocz, Katalin [1 ]
Szinger, David [1 ]
Filipanits, Kristof [2 ]
Minier, Tuende [2 ]
Kumanovics, Gabor [2 ]
Czirjak, Laszlo [2 ]
Berki, Timea [1 ]
Simon, Diana [1 ]
机构
[1] Univ Pecs, Clin Ctr, Dept Immunol & Biotechnol, Med Sch, H-7624 Pecs, Hungary
[2] Univ Pecs, Clin Ctr, Med Sch, Dept Rheumatol & Immunol, H-7632 Pecs, Hungary
关键词
CD180; systemic sclerosis; complement receptors; Toll-like receptors; natural autoantibodies; B cells; C3; anti-Scl-70; autoantibodies; NATURAL ANTIBODY; ACTIVATION; CLASSIFICATION; AUTOANTIBODIES; CYTOTOXICITY; PATHOGENESIS; ENDOTHELIUM; MECHANISMS; CR-2;
D O I
10.3390/ijms25179230
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autoantibody production is a hallmark of systemic sclerosis (SSc) and the most extensively studied role of B cells in the pathogenesis of the disease. However, the potential involvement of innate immune molecules in B-cell dysfunction in SSc is less understood. B-cell activation is an early event in the pathogenesis of SSc and is influenced by complement receptors (CRs) and Toll-like receptors (TLRs), shaping antibody responses. CR2 and CR1 modulate B-cell activation, and the roles of CR3 and CR4 are associated with autoimmune conditions. We investigated the expression of CRs in B cells from patients with the more severe form of the disease, diffuse cutaneous SSc (dcSSc), and the effect of TLR CD180 ligation on their expression. We found no significant difference in the basal expression of CD21 and CD11c in B cells between dcSSc and healthy controls (HCs). However, reduced basal CD11b expression in B cells in dcSSc compared to HCs, accompanied by a decrease in CD35 and an increase in CD11c expression following CD180 ligation may promote plasma cell formation and autoantibody production. Additionally, we searched for correlations between dcSSc-associated anti-DNA topoisomerase I (Scl-70) autoantibody, anti-citrate synthase (CS) natural autoantibody and complement component 3 (C3) levels and found a negative correlation between C3 and anti-CS autoantibody in dcSSc but not in HCs, supporting the hypothesis that natural autoantibodies could activate the complement system contributing to tissue injury in SSc.
引用
收藏
页数:9
相关论文
共 47 条
  • [1] Toll-like Receptor Homologue CD180 Ligation of B Cells Upregulates Type I IFN Signature in Diffuse Cutaneous Systemic Sclerosis
    Erdo-Bonyar, Szabina
    Rapp, Judit
    Subicz, Rovena
    Filipanits, Kristof
    Minier, Tunde
    Kumanovics, Gabor
    Czirjak, Laszlo
    Berki, Timea
    Simon, Diana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
  • [2] Rewiring of sIgM-Mediated Intracellular Signaling through the CD180 Toll-like Receptor
    Porakishvili, Nino
    Vispute, Ketki
    Steele, Andrew J.
    Rajakaruna, Nadeeka
    Kulikova, Nina
    Tsertsvadze, Tamar
    Nathwani, Amit
    Damle, Rajendra N.
    Clark, Edward A.
    Rai, Kanti R.
    Chiorazzi, Nicholas
    Lydyard, Peter M.
    MOLECULAR MEDICINE, 2015, 21 : 46 - 57
  • [3] Toll-like receptor 10 expression in B cells is negatively correlated with the progression of primary Sjogren's disease
    Lai, Nannan
    Qian, YiChao
    Wu, Yilin
    Jiang, Xi
    Sun, Honghua
    Luo, Zhaofan
    Zhao, Yanli
    Zeng, Changchun
    Zheng, Xiaoming
    Zhan, Xiao-Yong
    Tang, Chun
    Wang, Qingwen
    Huang, Bihui
    CLINICAL IMMUNOLOGY, 2022, 237
  • [4] The effect of systemic corticosteroid therapy on the expression of toll-like receptor 2 and toll-like receptor 4 in the cutaneous lesions of leprosy Type 1 reactions
    Walker, S. L.
    Roberts, C. H.
    Atkinson, S. E.
    Khadge, S.
    Macdonald, M.
    Neupane, K. D.
    Ranjit, C.
    Sapkota, B. R.
    Dhakal, S.
    Hawksworth, R. A.
    Mahat, K.
    Ruchal, S.
    Hamal, S.
    Hagge, D. A.
    Lockwood, D. N. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 (01) : 29 - 35
  • [5] An Unexpected Intriguing Effect of Toll-Like Receptor Regulator RP105 (CD180) on Atherosclerosis Formation With Alterations on B-Cell Activation
    Karper, J. C.
    de Jager, S. C. A.
    Ewing, M. M.
    de Vries, M. R.
    Bot, I.
    van Santbrink, P. J.
    Redeker, A.
    Mallat, Z.
    Binder, C. J.
    Arens, R.
    Jukema, J. W.
    Kuiper, J.
    Quax, P. H. A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (12) : 2810 - 2817
  • [6] CD19 controls Toll-like receptor 9 responses in human B cells
    Morbach, Henner
    Schickel, Jean-Nicolas
    Cunningham-Rundles, Charlotte
    Conley, Mary Ellen
    Reisli, Ismail
    Luis Franco, Jose
    Meffre, Eric
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (03) : 889 - +
  • [7] IgE Inhibits Toll-like Receptor 7-and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus
    Khoryati, Liliane
    Augusto, Jean-Francois
    Shipley, Emilie
    Contin-Bordes, Cecile
    Douchet, Isabelle
    Mitrovic, Stephane
    Truchetet, Marie-Elise
    Lazaro, Estibaliz
    Duffau, Pierre
    Couzi, Lionel
    Jacquemin, Clement
    Barnetche, Thomas
    Vacher, Pierre
    Schaeverbeke, Thierry
    Blanco, Patrick
    Richez, Christophe
    ARTHRITIS & RHEUMATOLOGY, 2016, 68 (09) : 2221 - 2231
  • [8] Ligation of TLR Homologue CD180 of B Cells Activates the PI3K/Akt/mTOR Pathway in Systemic Sclerosis and Induces a Pathological Shift in the Expression of BAFF Receptors
    Erdo-Bonyar, Szabina
    Rapp, Judit
    Szinger, David
    Minier, Tunde
    Kumanovics, Gabor
    Czirjak, Laszlo
    Berki, Timea
    Simon, Diana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (12)
  • [9] Toll-like receptor 2 induces mucosal homing receptor expression and IgA production by human B cells
    Liang, YanMei
    Hasturk, Hatice
    Elliot, Jennifer
    Noronha, Ansu
    Liu, Xiuping
    Wetzler, Lee M.
    Massari, Paola
    Kantarci, Alpdogan
    Winter, Harland S.
    Farraye, Francis A.
    Ganley-Leal, Lisa M.
    CLINICAL IMMUNOLOGY, 2011, 138 (01) : 33 - 40
  • [10] The expression profile of toll-like receptor signaling molecules in CD19+ B cells from patients with primary immune thrombocytopenia
    Hua, Fanli
    Li, Ying
    Zhao, Xin
    Zhang, Dawei
    Zhan, Yanxia
    Ji, Lili
    Gao, Song
    Meng, Yuesheng
    Li, Feng
    Zou, Shanhua
    Cheng, Yunfeng
    IMMUNOLOGY LETTERS, 2016, 176 : 28 - 35